Source link : https://www.newshealth.biz/health-news/fda-approves-jak-inhibitor-for-alopecia-areata/
The US Food and Drug Administration (FDA) has approved the oral Janus kinase (JAK) inhibitor deuruxolitinib for the treatment of adults with severe alopecia areata. The development, which was announced in a July 25, 2024, news release from the drug’s manufacturer Sun Pharma, is based on data from two pivotal randomized, double-blind, placebo-controlled phase 3 […]
Author : News Health
Publish date : 2024-07-26 14:52:49
Copyright for syndicated content belongs to the linked Source.
inHealth